DaVita [DVA] vs Option Care Health [OPCH] Detailed Stock Comparison
DaVita
NYSE
Loading...
Option Care Health
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: DaVita wins in 15 metrics, Option Care Health wins in 4 metrics, with 0 ties. DaVita appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | DaVita | Option Care Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.45 | 22.37 | DaVita |
| Price-to-Book Ratio | 6.68 | 3.36 | Option Care Health |
| Debt-to-Equity Ratio | 825.19 | 90.35 | Option Care Health |
| PEG Ratio | 5.74 | 22.37 | DaVita |
| EV/EBITDA | 8.84 | 13.99 | DaVita |
| Profit Margin (TTM) | 6.35% | 3.93% | DaVita |
| Operating Margin (TTM) | 15.70% | 5.84% | DaVita |
| EBITDA Margin (TTM) | 15.70% | 5.84% | DaVita |
| Return on Equity | 57.94% | 15.25% | DaVita |
| Return on Assets (TTM) | 7.15% | 6.20% | DaVita |
| Free Cash Flow (TTM) | $1.47B | $287.79M | DaVita |
| 1-Year Return | -10.66% | -12.54% | DaVita |
| Price-to-Sales Ratio (TTM) | 0.74 | 0.85 | DaVita |
| Enterprise Value | $23.77B | $5.60B | DaVita |
| EV/Revenue Ratio | 1.81 | 1.04 | Option Care Health |
| Gross Profit Margin (TTM) | 33.08% | 19.00% | DaVita |
| Revenue per Share (TTM) | $164 | $32 | DaVita |
| Earnings per Share (Diluted) | $10.16 | $1.26 | DaVita |
| Beta (Stock Volatility) | 1.09 | 0.79 | Option Care Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
DaVita vs Option Care Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| DaVita | 0.12% | 2.37% | -1.33% | -2.32% | -3.38% | -8.17% |
| Option Care Health | 2.28% | -2.01% | -4.56% | -14.89% | -13.00% | 22.64% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| DaVita | -10.66% | 55.19% | 58.25% | 80.34% | 320.48% | 517.78% |
| Option Care Health | -12.54% | -11.87% | 136.13% | 182.93% | 36.20% | 13.54% |
Performance & Financial Health Analysis: DaVita vs Option Care Health
| Metric | DVA | OPCH |
|---|---|---|
| Market Information | ||
| Market Cap | $9.77B | $4.58B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,051,160 | 1,458,340 |
| 90 Day Avg. Volume | 841,127 | 1,510,077 |
| Last Close | $137.58 | $27.84 |
| 52 Week Range | $126.07 - $179.60 | $21.39 - $35.53 |
| % from 52W High | -23.40% | -21.64% |
| All-Time High | $179.60 (Jan 27, 2025) | $91.80 (Apr 22, 2002) |
| % from All-Time High | -23.40% | -69.67% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.15% |
| Quarterly Earnings Growth | -0.11% | -0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.04% |
| Operating Margin (TTM) | 0.16% | 0.06% |
| Return on Equity (TTM) | 0.58% | 0.15% |
| Debt to Equity (MRQ) | 825.19 | 90.35 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-4.98 | $8.38 |
| Cash per Share (MRQ) | $10.34 | $1.27 |
| Operating Cash Flow (TTM) | $1.86B | $279.64M |
| Levered Free Cash Flow (TTM) | $1.10B | $194.12M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: DaVita vs Option Care Health
| Metric | DVA | OPCH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.45 | 22.37 |
| Forward P/E | 12.13 | 22.37 |
| PEG Ratio | 5.74 | 22.37 |
| Price to Sales (TTM) | 0.74 | 0.85 |
| Price to Book (MRQ) | 6.68 | 3.36 |
| Market Capitalization | ||
| Market Capitalization | $9.77B | $4.58B |
| Enterprise Value | $23.77B | $5.60B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.81 | 1.04 |
| Enterprise to EBITDA | 8.84 | 13.99 |
| Risk & Other Metrics | ||
| Beta | 1.09 | 0.79 |
| Book Value per Share (MRQ) | $-4.98 | $8.38 |
Financial Statements Comparison: DaVita vs Option Care Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DVA | OPCH |
|---|---|---|
| Revenue/Sales | $3.22B | $1.33B |
| Cost of Goods Sold | $2.24B | $1.07B |
| Gross Profit | $983.87M | $263.05M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $433.33M | $79.19M |
| EBITDA | $597.84M | $93.16M |
| Pre-Tax Income | $286.33M | $63.56M |
| Income Tax | $54.12M | $16.81M |
| Net Income (Profit) | $232.22M | $46.74M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DVA | OPCH |
|---|---|---|
| Cash & Equivalents | $438.78M | $198.82M |
| Total Current Assets | $3.64B | $1.18B |
| Total Current Liabilities | $2.91B | $773.62M |
| Long-Term Debt | $11.72B | $1.20B |
| Total Shareholders Equity | $1.66B | $1.36B |
| Retained Earnings | $1.70B | $766.60M |
| Property, Plant & Equipment | $11.65B | $134.76M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DVA | OPCH |
|---|---|---|
| Operating Cash Flow | $287.94M | $-46.97M |
| Capital Expenditures | $-143.26M | $-9.37M |
| Free Cash Flow | $36.75M | $-16.59M |
| Debt Repayment | $-345.97M | $-1.63M |
| Common Stock Repurchase | $-541.85M | $-100.22M |
Short Interest & Institutional Ownership Analysis
| Metric | DVA | OPCH |
|---|---|---|
| Shares Short | 6.11M | 4.95M |
| Short Ratio | 8.22 | 3.37 |
| Short % of Float | 0.16% | 0.05% |
| Average Daily Volume (10 Day) | 1,051,160 | 1,458,340 |
| Average Daily Volume (90 Day) | 841,127 | 1,510,077 |
| Shares Outstanding | 80.54M | 166.26M |
| Float Shares | 35.70M | 152.93M |
| % Held by Insiders | 0.50% | 0.01% |
| % Held by Institutions | 0.52% | 1.02% |
Dividend Analysis & Yield Comparison: DaVita vs Option Care Health
| Metric | DVA | OPCH |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |